The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Gabapentin Rosemont 50mg/ml Oral Solution

50 milligram(s)/millilitre Oral solution

Perrigo Pharma International Designated Activity CompanyPA22741/008/001

Main Information

Trade NameGabapentin Rosemont 50mg/ml Oral Solution
Active SubstancesGabapentin
Strength50 milligram(s)/millilitre
Dosage FormOral solution
Licence HolderPerrigo Pharma International Designated Activity Company
Licence NumberPA22741/008/001

Group Information

ATC CodeN03AX Other antiepileptics
N03AX12 gabapentin

Status

Authorised/WithdrawnAuthorised
Licence Issued26/10/2012
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back